• About Us
    • Members
    • Constitution
    • Leadership
    • Advisory Board
    • HQ Structure
    • Sponsors
  • Meetings
    • CSEA3 Annual Congress 2026​
    • Expert Meeting 2025
  • Projects
    • CARES registry
    • CASA-IG guidelines
    • SEASON survey
  • Resources
    • Recommended Research Articles
  • About Us
    • Members
    • Constitution
    • Leadership
    • Advisory Board
    • HQ Structure
    • Sponsors
  • Meetings
    • CSEA3 Annual Congress 2026​
    • Expert Meeting 2025
  • Projects
    • CARES registry
    • CASA-IG guidelines
    • SEASON survey
  • Resources
    • Recommended Research Articles
Get in touch
Insights

admin

Uncategorized

The CSEA3 participated in the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) Congress 2025, held in Jakarta, Indonesia, from October 9–12, 2025

article

Comparative Evaluation of an Allergen Exposure Chamber and Nasal Allergen Challenge Versus In-Field Symptom Assessment in Patients With Allergic Rhinitis Triggered by Timothy Grass Pollen

article

Serum Allergen-Specific IgE among Pediatric Patients with Primary Immunodeficiency

article

Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation

article

Real-world evidence for the long-term effect of allergen immunotherapy: Current status on database-derived European studies

article

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long-term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis

article

Histamine: A Mediator of Intestinal Disorders-A Review

article

Immunotherapy: State-of-the-art review of therapies and theratypes

article

Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study

article

Persistence in allergen immunotherapy: A longitudinal, prescription data-based real-world analysis

Load More

Wrocław, PL

53-201 Wrocław, Al. Gen. Józefa Hallera 95, Poland

Registered in the National Court Register (KRS) under No. 0000304933

contact@csea3.eu

Members
MEETINGS
Projects
Leadership
sponsors
©2026
CSEA3. All rights reserved.
©2026
Payment policy, terms and conditions
top

Inactive

Inactive

Office

The Central & Southern European Allergy and Asthma Alliance (CSEA3)
headquartered at 53-201 Wrocław,
al. Gen. Józefa Hallera 95, Poland.
Registered in the Commercial Register (KRS) under No. 0000304933
contact@csea3.eu

Let's stay in touch!

Contact us